HERCULES, Calif.--(BUSINESS WIRE)-- Bio-Rad Laboratories, Inc. (BIO.B), a global leader in life science research and clinical diagnostics products, today announced the launch of four new Droplet ...
Bio-Rad Laboratories, Inc. BIO is expected to release first-quarter 2024 results on May 2 after the closing bell. The company posted adjusted earnings per share (EPS) of $3.10 in the last reported ...
HERCULES, Calif.--(BUSINESS WIRE)--Bio-Rad Laboratories, Inc. (NYSE: BIO and BIO.B), a global leader in life science research and clinical diagnostics products, today announced that the company has ...
We recently compiled a list of 10 Most Undervalued Healthcare Stocks to Buy According to Analysts. Bio-Rad Laboratories, Inc. stands tenth on our list and is currently making waves for launching a new ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback